Policy pinings Viveka Roychowdhury Mar 6, 2015 As in previous years, we mark this Women's Day with a cover story section devoted to women's health issue
The politics of IPR policy Viveka Roychowdhury Feb 20, 2015 The draft National IPR policy, unveiled last December by the Department of Industrial Policy & Promotion (DIPP), has already…
‘The health industry as a whole has a positive future’ Viveka Roychowdhury Feb 5, 2015 In a free-wheeling conversation with Viveka Roychowdhury, Patrick Figgis, Global Health Leader, PwC and Sujay Shetty,…
Panacea Biotec: A Turnaround Story Viveka Roychowdhury Feb 4, 2015 After three consecutive years of negative EBITDA, Panacea Biotec looks set to script a successful revival. Dr Rajesh Jain, Joint…
The bigger picture vs the nitty-gritty Viveka Roychowdhury Jan 27, 2015 While we are urged to look beyond the sticky issues, one cannot overlook the final impact of decisions on India's IPR policy
Pet vs Glass: Who will blink first? Viveka Roychowdhury Jan 22, 2015 The Health Ministry has predictably stirred a hornet's nest with its diktat to replace PET with glass packaging for certain…
Could a surgeon become DCG(I)? Viveka Roychowdhury Jan 16, 2015 CDSCO's planned 'harmonisation of recruitment rules' is sure to resurrect this debate
Forecast 2015: Hope springs eternal Viveka Roychowdhury Jan 6, 2015 As the adage goes, look before you leap
‘The government could do more in terms of how it sees research activities’ Viveka Roychowdhury Dec 23, 2014 The government is doing many positive things in the biosciences, but could do more, in terms of how it sees research activities,…
Learnings from the GVK BIO saga Viveka Roychowdhury Dec 20, 2014 Now that India’s competition watch dog, the Competition Commission of India (CCI) has given its nod to Sun Pharma’s acquisition of…